279 related articles for article (PubMed ID: 32815406)
1. Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an
Kumar A; Kumar P; Saumya KU; Kapuganti SK; Bhardwaj T; Giri R
Expert Rev Vaccines; 2020 Sep; 19(9):887-898. PubMed ID: 32815406
[TBL] [Abstract][Full Text] [Related]
2. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
[TBL] [Abstract][Full Text] [Related]
3. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
[TBL] [Abstract][Full Text] [Related]
4. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
[TBL] [Abstract][Full Text] [Related]
5. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
Dong R; Chu Z; Yu F; Zha Y
Front Immunol; 2020; 11():1784. PubMed ID: 32849643
[TBL] [Abstract][Full Text] [Related]
6. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach.
Ahammad I; Lira SS
Int J Biol Macromol; 2020 Nov; 162():820-837. PubMed ID: 32599237
[TBL] [Abstract][Full Text] [Related]
7. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2.
Kalita P; Padhi AK; Zhang KYJ; Tripathi T
Microb Pathog; 2020 Aug; 145():104236. PubMed ID: 32376359
[TBL] [Abstract][Full Text] [Related]
8. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M
Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041
[TBL] [Abstract][Full Text] [Related]
9. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C
J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
11. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach.
Naz A; Shahid F; Butt TT; Awan FM; Ali A; Malik A
Front Immunol; 2020; 11():1663. PubMed ID: 32754160
[TBL] [Abstract][Full Text] [Related]
12. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
[TBL] [Abstract][Full Text] [Related]
13. A candidate multi-epitope vaccine against SARS-CoV-2.
Kar T; Narsaria U; Basak S; Deb D; Castiglione F; Mueller DM; Srivastava AP
Sci Rep; 2020 Jul; 10(1):10895. PubMed ID: 32616763
[TBL] [Abstract][Full Text] [Related]
14. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
Noorimotlagh Z; Karami C; Mirzaee SA; Kaffashian M; Mami S; Azizi M
Int Immunopharmacol; 2020 Sep; 86():106738. PubMed ID: 32683296
[TBL] [Abstract][Full Text] [Related]
15. Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain:
Chukwudozie OS; Chukwuanukwu RC; Iroanya OO; Eze DM; Duru VC; Dele-Alimi TO; Kehinde BD; Bankole TT; Obi PC; Okinedo EU
J Immunol Res; 2020; 2020():2837670. PubMed ID: 32964056
[TBL] [Abstract][Full Text] [Related]
16. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
17. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.
Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB
Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069
[TBL] [Abstract][Full Text] [Related]
18. High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19.
Ojha R; Gupta N; Naik B; Singh S; Verma VK; Prusty D; Prajapati VK
Eur J Pharm Sci; 2020 Aug; 151():105375. PubMed ID: 32417398
[TBL] [Abstract][Full Text] [Related]
19. Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.
Lon JR; Bai Y; Zhong B; Cai F; Du H
Virol J; 2020 Oct; 17(1):165. PubMed ID: 33121513
[TBL] [Abstract][Full Text] [Related]
20. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O
Front Immunol; 2020; 11():2008. PubMed ID: 33013857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
